BACKGROUND AND PURPOSE: : Proton radiation has been used for the treatment ofuveal melanoma since 1975, but few studies have been conducted to assess itsefficacy and safety. This paper aims to systematically review the effects andside effects of proton therapy for any indication of the eye.MATERIAL AND METHODS: : A range of databases were searched from inception to2007. All studies that included at least ten patients and that assessed theefficacy or safety of proton therapy for any indication of the eye were included.RESULTS: : The search generated 2,385 references, of which 37 met the inclusioncriteria. Five controlled trials, two comparative studies and 30 case series werefound, most often reporting on uveal melanoma, choroidal melanoma and age-relatedmacular degeneration (AMD). Methodological quality of these studies was poor.Studies were characterized by large differences in radiation techniques appliedwithin the studies, and by variation in patient characteristics within andbetween studies. Results for uveal melanoma and choroidal melanoma suggestfavorable survival, with, however, significant rates of side effects. Results forchoroidal hemangioma and AMD did not reveal beneficial effects from protonradiation.CONCLUSION: : There is limited evidence on the effectiveness and safety of protonradiation due to the lack of well-designed and well-reported studies. There is a need to lift evidence on proton therapy to a higher level by performingdose-finding randomized controlled trials (RCTs), comparative studies of protonradiation versus standard given alternatives and prospective case studiesenrolling only patients treated with up-to-date techniques, allowingextrapolation of results to similar patient groups.

The effectiveness and safety of proton radiation therapy for indications of the eye : a systematic review

Rutjes A;
2009-01-01

Abstract

BACKGROUND AND PURPOSE: : Proton radiation has been used for the treatment ofuveal melanoma since 1975, but few studies have been conducted to assess itsefficacy and safety. This paper aims to systematically review the effects andside effects of proton therapy for any indication of the eye.MATERIAL AND METHODS: : A range of databases were searched from inception to2007. All studies that included at least ten patients and that assessed theefficacy or safety of proton therapy for any indication of the eye were included.RESULTS: : The search generated 2,385 references, of which 37 met the inclusioncriteria. Five controlled trials, two comparative studies and 30 case series werefound, most often reporting on uveal melanoma, choroidal melanoma and age-relatedmacular degeneration (AMD). Methodological quality of these studies was poor.Studies were characterized by large differences in radiation techniques appliedwithin the studies, and by variation in patient characteristics within andbetween studies. Results for uveal melanoma and choroidal melanoma suggestfavorable survival, with, however, significant rates of side effects. Results forchoroidal hemangioma and AMD did not reveal beneficial effects from protonradiation.CONCLUSION: : There is limited evidence on the effectiveness and safety of protonradiation due to the lack of well-designed and well-reported studies. There is a need to lift evidence on proton therapy to a higher level by performingdose-finding randomized controlled trials (RCTs), comparative studies of protonradiation versus standard given alternatives and prospective case studiesenrolling only patients treated with up-to-date techniques, allowingextrapolation of results to similar patient groups.
2009
Wirksamkeit und Verträglichkeit von Protonenstrahltherapien für ophthalmologische Indikationen.Eine systematische ÜbersichtHintergrund und Ziel: Protonenstrahlen werden seit 1975 zur Behandlung von Uveamelanomen eingesetzt, aber nur wenigeStudien haben die Wirksamkeit und Verträglichkeit der Behandlung untersucht. Ziel dieser Studie war die Erstellung einer systematischenÜbersicht der Wirksamkeit und Verträglichkeit von Protonenstrahltherapien für alle ophthalmologischen Indikationen.Material und Methodik: Suche in diversen Databanken über den Zeitraum von der Einführung bis zum Jahr 2007. Einbezogenwurden alle Studien, in die mindestens zehn Patienten eingeschlossen wurden und deren Ziel es war, die Wirksamkeit oder Verträglichkeitder Protonenstrahltherapie für beliebige ophthalmologische Indikationen zu untersuchen.Ergebnisse: Die Suche ergab 2 385 Treffer; davon erfüllten 37 Studien die Selektionskriterien. Es handelte sich um fünf kontrollierteStudien, zwei vergleichende Studien und 30 Fallstudien. Die meisten Arbeiten betrafen Uveamelanome, Aderhautmelanomeund altersbedingte Makuladegeneration (AMD). Die methodische Qualität dieser Studien war niedrig. Es bestanden großeUnterschiede bei den angewendeten Strahlungsprotokollen und den Patienteneigenschaften, nicht nur zwischen, sondern auchinnerhalb der Studien. Die Resultate für Uveamelanome und Aderhautmelanome wiesen auf einen positiven Effekt bezüglich der Überlebensrate hin, allerdings in Verbindung mit beachtlichen Komplikationsraten. Die Ergebnisse für Aderhautmelanome undAMD zeigten keine günstigen Auswirkungen der Protonstrahlbehandlung.Schussfolgerung: Aufgrund des Mangels an gut geplanten und gut dokumentierten Studien ist die Evidenz für die Wirksamkeitund Sicherheit der Protonenstrahlbehandlung gering. Um einen höheren Evidenzgrad zu erreichen, ist es erforderlich, randomisierte,kontrollierte Studien (RCTs) zur Dosisfindung und zum Vergleich zwischen Standard- und Protonenstrahltherapie ineinem prospektiven Design unter Anwendung moderner Techniken durchzuführen, was die Extrapolation der Daten auf ähnlichePatientengruppen zulässt.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14245/10689
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 22
social impact